These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 27817220)

  • 21. Nonalcoholic fatty liver disease is associated with low circulating levels of insulin-like growth factor-I.
    Arturi F; Succurro E; Procopio C; Pedace E; Mannino GC; Lugarà M; Procopio T; Andreozzi F; Sciacqua A; Hribal ML; Perticone F; Sesti G
    J Clin Endocrinol Metab; 2011 Oct; 96(10):E1640-4. PubMed ID: 21816784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 1H-MRS Measured Ectopic Fat in Liver and Muscle in Danish Lean and Obese Children and Adolescents.
    Fonvig CE; Chabanova E; Andersson EA; Ohrt JD; Pedersen O; Hansen T; Thomsen HS; Holm JC
    PLoS One; 2015; 10(8):e0135018. PubMed ID: 26252778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The DGAT2 gene is a candidate for the dissociation between fatty liver and insulin resistance in humans.
    Kantartzis K; Machicao F; Machann J; Schick F; Fritsche A; Häring HU; Stefan N
    Clin Sci (Lond); 2009 Mar; 116(6):531-7. PubMed ID: 18980578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High circulating retinol-binding protein 4 is associated with elevated liver fat but not with total, subcutaneous, visceral, or intramyocellular fat in humans.
    Stefan N; Hennige AM; Staiger H; Machann J; Schick F; Schleicher E; Fritsche A; Häring HU
    Diabetes Care; 2007 May; 30(5):1173-8. PubMed ID: 17259477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Subtle Balance between Lipolysis and Lipogenesis: A Critical Point in Metabolic Homeostasis.
    Saponaro C; Gaggini M; Carli F; Gastaldelli A
    Nutrients; 2015 Nov; 7(11):9453-74. PubMed ID: 26580649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fatty pancreas, insulin resistance, and β-cell function: a population study using fat-water magnetic resonance imaging.
    Wong VW; Wong GL; Yeung DK; Abrigo JM; Kong AP; Chan RS; Chim AM; Shen J; Ho CS; Woo J; Chu WC; Chan HL
    Am J Gastroenterol; 2014 Apr; 109(4):589-97. PubMed ID: 24492753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anthropometric measures of visceral and subcutaneous fat are important in the determination of metabolic dysregulation in boys and girls at risk for nonalcoholic fatty liver disease.
    Mager DR; Yap J; Rodriguez-Dimitrescu C; Mazurak V; Ball G; Gilmour S
    Nutr Clin Pract; 2013 Feb; 28(1):101-11. PubMed ID: 23042833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?
    Bhatia LS; Curzen NP; Calder PC; Byrne CD
    Eur Heart J; 2012 May; 33(10):1190-200. PubMed ID: 22408036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A double-blind, placebo-controlled randomized trial to evaluate the efficacy of docosahexaenoic acid supplementation on hepatic fat and associated cardiovascular risk factors in overweight children with nonalcoholic fatty liver disease.
    Pacifico L; Bonci E; Di Martino M; Versacci P; Andreoli G; Silvestri LM; Chiesa C
    Nutr Metab Cardiovasc Dis; 2015 Aug; 25(8):734-41. PubMed ID: 26026214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity.
    Bugianesi E; Pagotto U; Manini R; Vanni E; Gastaldelli A; de Iasio R; Gentilcore E; Natale S; Cassader M; Rizzetto M; Pasquali R; Marchesini G
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3498-504. PubMed ID: 15797948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease.
    Zhao L; Cang Z; Sun H; Nie X; Wang N; Lu Y
    BMC Endocr Disord; 2017 Feb; 17(1):13. PubMed ID: 28241817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating vaspin levels and epicardial adipose tissue thickness are associated with impaired coronary flow reserve in patients with nonalcoholic fatty liver disease.
    Yilmaz Y; Kurt R; Gurdal A; Alahdab YO; Yonal O; Senates E; Polat N; Eren F; Imeryuz N; Oflaz H
    Atherosclerosis; 2011 Jul; 217(1):125-9. PubMed ID: 21513939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatic Steatosis and Insulin Resistance, But Not Steatohepatitis, Promote Atherogenic Dyslipidemia in NAFLD.
    Bril F; Sninsky JJ; Baca AM; Superko HR; Portillo Sanchez P; Biernacki D; Maximos M; Lomonaco R; Orsak B; Suman A; Weber MH; McPhaul MJ; Cusi K
    J Clin Endocrinol Metab; 2016 Feb; 101(2):644-52. PubMed ID: 26672634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gender-specific prevalences of fatty liver in obese children and adolescents: roles of body fat distribution, sex steroids, and insulin resistance.
    Denzer C; Thiere D; Muche R; Koenig W; Mayer H; Kratzer W; Wabitsch M
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3872-81. PubMed ID: 19773396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Not all fats are created equal: adipose vs. ectopic fat, implication in cardiometabolic diseases.
    Gaggini M; Saponaro C; Gastaldelli A
    Horm Mol Biol Clin Investig; 2015 Apr; 22(1):7-18. PubMed ID: 25816312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CPAP therapy induces favorable short-term changes in epicardial fat thickness and vascular and metabolic markers in apparently healthy subjects with obstructive sleep apnea-hypopnea syndrome (OSAHS).
    Kostopoulos K; Alhanatis E; Pampoukas K; Georgiopoulos G; Zourla A; Panoutsopoulos A; Kallianos A; Velentza L; Zarogoulidis P; Trakada G
    Sleep Breath; 2016 May; 20(2):483-93. PubMed ID: 26223484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Fatty liver and global cardiometabolic risk].
    Szollár L
    Orv Hetil; 2010 Nov; 151(47):1946-50. PubMed ID: 21071306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type II diabetes mellitus.
    Heilbronn L; Smith SR; Ravussin E
    Int J Obes Relat Metab Disord; 2004 Dec; 28 Suppl 4():S12-21. PubMed ID: 15592481
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin Resistance but Not Visceral Adiposity Index Is Associated with Liver Fibrosis in Nondiabetic Subjects with Nonalcoholic Fatty Liver Disease.
    Ercin CN; Dogru T; Genc H; Celebi G; Aslan F; Gurel H; Kara M; Sertoglu E; Tapan S; Bagci S; Rizzo M; Sonmez A
    Metab Syndr Relat Disord; 2015 Sep; 13(7):319-25. PubMed ID: 26011302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relation of physical activity to prevalence of nonalcoholic Fatty liver disease independent of cardiometabolic risk.
    Oni ET; Kalathiya R; Aneni EC; Martin SS; Blaha MJ; Feldman T; Agatston AS; Blumenthal RS; Conceiçao RD; Carvalho JA; Santos RD; Nasir K
    Am J Cardiol; 2015 Jan; 115(1):34-9. PubMed ID: 25456868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.